Adjunctive fluvoxamine with clozapine [4]

British Journal of Psychiatry

Volumn 182, Issue JAN., 2003, Pages 81-

  Lu, M L ^a   Lane, H Y ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; FLUVOXAMINE; NORCLOZAPINE;

DEPRESSION; DRUG EFFICACY; DRUG INDICATION; DRUG POTENTIATION; HUMAN; LETTER;

ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FLUVOXAMINE; HUMANS; SCHIZOPHRENIA;

EID: 0345382865     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.182.1.81     Document Type: Letter

References (5)

1. Armstrong, S. C. & Cozza, K. L. (2001) Consultation-liaison psychiatry drug-drug interactions update. Psychosomatics, 42, 157-159.
2. Lu, M. L., Lane, H.Y., Chen, K. P., et al (2000) Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. Journal of Clinical Psychiatry, 61, 594-599.
3. Olesen, O.V. & Linnet, K. (2000) Fluvoxamine-clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism. Journal of Clinical Psychopharmacology, 20, 35-42.
4. Wetzel, H., Anghclescu, I., Szegedi, A., et al (1998) Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study. Journal of Clinical Psychopharmacology, 18, 2-9.
5. Williams, L., Newton, G., Roberts, K., et al (2002) Clozapine-resistant schizophrenia: a positive approach. British Journal of Psychiatry, 181, 184-187.